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Abstract
Background: Rapid detection of carbapenem resistant bacteria, in particular, 
members of the Enterobacteriaceae family (CRE), is of utmost importance for the 
management of infected or colonized patients.
Methods: Three carbapenems; meropenem, imipenem and ertapenem, with two 
different concentrations (0.5 mg/ml and 1.0 mg/ml), were impregnated in Mac-
Conkey agar. The carbapenem impregnated MacConkey agar plates; ([Mac-Mem], 
[Mac-Imp] and [Mac-Ert]), were then evaluated for the detection of carbapenem 
resistant Gram-negative bacteria in particular the blaKPC producing Enterobacteria-
ceae. The Limit of Detection (LOD) of the plates was determined in triplicate after 
serial logarithmic dilution of the bacterial strains in saline. This was followed by 
inoculating the plates and counting the colonies that grew after 24 hours of incu-
bation. The specificity and the shelf-life of the plates were determined by testing 
the plates with six Extended Spectrum β-lactamases (ESBL) producing members 
of the Enterobacteriaceae family and one genus with the blaAmpC phenotype. 
Finally, the 0.5 mg/ml Mac-Mem plates were further challenged by incorporating 
them in the routine active surveillance program for the detection of carbapenem 
resistant bacteria. 
Results: Of the three carbapenems impregnated plates, Mac-Ert plates gave the 
lowest LOD; however, its specificity was poor as it failed to inhibit the growth of 
some of the ESBL producing strains. The Mac-Imp plate LOD and specificity were 
both unsatisfactory for several strains of the bacterial isolates tested. On the other 
hand the 0.5 mg/ml Mac-Mem plates showed low LOD for the blaKPC producing 
bacteria and had excellent specificity as it prevented the growth of all the ESBL 
and blaAmpC positive isolates tested. Not only that, but the shelf-life of the 0.5mg/
ml Mac-Mem plate was long, up to one month at 4oC. 
Conclusions: The high specificity and the good selectivity, in addition to the long 
shelf-life allowed the 0.5µg/ml Mac-Mem agar to be used as a cost effective selec-
tive medium for the isolation of carbapenem resistant Gram-negative bacteria, in 
particular the blaKPC producing members of the Enterobacteriaceae family. 
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Introduction
Rapid detection of carbapenem resistant bacteria, in par-
ticular, members of the Enterobacteriaceae family (CRE) is of 
utmost importance for the management of infected or colo-
nized patients (1). Carbapenems are widely used to treat se-
vere bacterial infections that are often hard to manage. Sever-
al carbapenem resistance mechanisms have been implicated 
in how bacterial strains become resistant to carbapenems. 
Based on the molecular properties of the β–lactamases, four 
classes of carbapenemases have been identified (2). These 
include the molecular classes (A, C, and D) β-lactamases with 
the amino acid serine at their active site, and the molecular 
class B where the β-lactamases are all metalloenzymes with 
an active-site zinc (2). Class A enzymes, an Ambler molecu-
lar class enzymes (ex: blaKPC), have been the most common 
detected carbapenemases with worldwide distribution (1). 
For any health care facility, it is important to understand the 
level of CRE spreading in its different medical departments. It 
has been recommended by the American Centers of Disease 
Control and Prevention (CDC), that in areas which are not 
endemic for CRE, the acute care facilities should review all 
the microbiology records for the preceding 6-12 months to 
determine if CRE’s have been isolated at the institution (3). 
Upon the identification of CRE cases, surveillance cultures 
from high risk areas should be performed to identify any 
unrecognized cases. 
CRE’s active surveillance cultures (perianal/rectal swabs), tak-
en from patients upon admission are of great importance for 
the identification of unrecognized CRE-colonized patients, in 
order to take immediate and appropriate isolation precau-
tions (4, 5). Studies have shown that in areas where CRE’s 
are endemic, up to 5.4% of hospitalized patients can be car-
riers of CRE’s, of which only one-third had a positive clinical 
culture (4). Moreover, surveillance swabs have been reported 
to considerably lower the cost of patient hospitalization (6). 
Active surveillance cultures taken from patients coming from 
highly CRE endemic medical settings upon admission have 
been used as part of a comprehensive strategy to combat the 
spread of CRE’s. Studies have shown a 4.7-fold reduction in 
the incidence of CRE infection following the activation of the 
active CRE surveillance program (7, 8).
 Several highly sensitive Polymerase Chain Reaction (PCR) as-
says and Real-Time PCR assays have been developed and 
validated for the rapid detection and identification of blaKPC 
positive bacteria (9-12). However, one of the disadvantages of 
these assays was the need for specialized equipment and well 
trained personnel. Consequently, screening agar plates, that 
have incorporated one of the commonly used carbapenems 
(ertapenem, meropenem or imipenem), have been developed 
and utilized for the rapid detection of blaKPC producing bac-
teria. Chromogenic agar, CHROMagarTM KPC (CHROMagar, 
France), has been evaluated for the detection of blaKPC posi-
tive bacteria. However, this agar base medium still missed 
certain strains of blaKPC positive Enterobacteriaceae (1, 13, 
14). Similar performance between the CHROMagarTM KPC 
and MacConkey Agar impregnated with 2 µg/ml imipenem 
was noted by Adler et al. (15). More recently, the Drigalski 
agar-based culture medium was reported to have excellent 
sensitivity and specificity for the detection of bacteria carry-
ing the blaKPC resistance mechanism (14). 
In this study, we report the evaluation of cost effective MacCo-
nkey Agar plates impregnated with one of the carbapenems 
(meropenem, imipenem and ertapenem) for the detection 
of CRE’s. In addition, the specificity, analytical sensitivity and 
the plates’ shelf-life were also evaluated. The concentrations 
of the antibiotics evaluated were 1.0 µg/mL and 0.5 µg/mL. 
These concentrations were chosen after careful evaluation 
of the carbapenems lowest minimal inhibitory concentration 
(MIC) interpretation guidelines published by the Clinical and 
Laboratory Standards Institute (CLSI) (17). 
Materials and Methods
Reagents
Meropenem trihydrate (Catalogue # M2574) and imipenem 
monohydrate (Catalogue # I0160) were supplied by Sig-
ma-Aldrich, USA. Ertapenem sodium, Invanz (Catalogue # 
7290004997960) was supplied by Merck Sharp and Dohme 
Corp, USA. All reagents were stored and diluted according 
to the manufacturer’s guidelines. 
Bacterial Strains
Carbapenem resistant Enterobacteriaceae members (N=9), 
Extended Spectrum β–Lactamases (ESBL) producing Entero-
bacteriaceae strains (N= 6), blaAmpC β-lactamase (N=1) and 
multi-drug resistant Acinetobacter baumannii (N=1), all iso-
lated from patients’ samples at Caritas Baby Hospital (CBH) 
laboratory, were used to evaluate the performance of the 
carbapenems impregnated MacConkey Agar. The carbap-
enem resistant isolates included: 3 Klebsiella pneumoniae 
blaKPC positive; 2 Enterobacter species blaKPC positive; 2 E. 
coli blaKPC positive; 1 Citrobacter species blaKPC positive and 
1 Klebsiella pneumoniae blaOXA-48 positive. The ESBL positive 
isolates were (K. pneumoniae, Salmonella species, Shigella 
sonnei, E. coli , Proteus species and Citrobacter species); while 
the blaAmpC positive bacteria was an Enterobacter species. 
Moreover, 14 Klebsiella pneumoniae blaOXA-48 positive and 
2 E. coli blaOXA-48 positive were used to evaluate the analyti-
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cal sensitivity of the 0.5 µg/ml Mac-Mem agar plates for the 
detection of low level carbapenemase producing blaOXA-48 
Enterobacteriaceae. 
All bacterial strains were identified according to the Clinical 
Microbiology Procedures Handbook, and their antimicrobial 
susceptibility testing was performed in duplicate according 
to the Clinical and Laboratory Standard Institute guidelines 
(CLSI) (16, 17). In addition, the Minimal Inhibitory Concentra-
tions (MIC) of meropenem, imipenem and ertapenem for all 
tested members of the Enterobacteriaceae family were deter-
mined using the Etest® (bioMérieux, France) on Mueller-Hin-
ton plates (Oxoid, UK). The presence of the carbapenemase 
enzyme in the members of the Enterobacteriaceae family was 
confirmed by the modified Hodge Test (17), and in duplicate 
by the Polymerase Chain Reaction (PCR) amplification of ei-
ther the blaKPC or the blaOXA-48 genes (18, 19).
Limit of Detection (LOD) of Carbapenems 
Impregnated MacConkey Agar Plates
Three types of carbapenem impregnated MacConkey agar 
plates (Mac-Mem, Mac-Imp and Mac-Ert), with two different 
concentrations (0.5 mg/ml and 1.0 mg/ml), were prepared and 
evaluated for the detection of carbapenem resistant bacteria. 
Bacterial strains were inoculated on 5% sheep blood agar 
(Hy-Lab, Rehovot) and incubated in ambient air at 35oC for 
18-24 hours. Well isolated colonies of the different strains 
were used to prepare bacterial suspensions equivalent to 0.5 
McFarland turbidity standard (1.5 x 108 CFU/ml) using Ox-
oid Turbidimeter (Oxoid, UK). This was followed by prepar-
ing serial logarithmic dilutions of 10 (1:10, 1:100, 1:1,000, 
1:10,000, 1:100,000, 1:1,000,000) for each isolate in nor-
mal saline. For each bacterial strain, an aliquot (100 ml) from 
each dilution was inoculated on the 0.5 mg/ml and 1.0 mg/
ml Mac-Mem, Mac-Imp and Mac-Ert plates in duplicate. Thus, 
the total number of plates used for checking each antibiotic 
concentration was 12 plates. In addition, a bacterial viability 
control was performed by inoculating all of the bacterial dilu-
tions on MacConkey with no carbapenems in duplicate. The 
inoculums were spread on the whole plate surface with a 
sterile plate spreader. All inoculated plates were incubated in 
ambient air at 35oC for 18-24 hours. Following incubation, 
bacterial colonies were counted and the LOD of each plate 
was determined by calculating the ratio between the number 
of colonies that grew on the MacConkey agar plates with 
and without antibiotic. Plates with less than 300 colonies 
were counted. The two tailed Student t-test was used to 
determine statistical significance between the LOD’s of the 
plates evaluated. 
Determination of the specificity and Shelf-Life of 
the different Carbapenems Impregnated Plates
MacConkey agar plates (Mac-Mem, Mac-Imp, and Mac-Ert) 
impregnated with the two different concentrations (0.5 µg/
ml and 1.0 µg/ml) of the three carbapenems, were prepared 
and stored at 4-8oC. The plates were inoculated with colonies 
from six members of the Enterobacteriaceae family (K. pneu-
moniae, Salmonella species, Shigella species, E. coli, Proteus 
species, and Citrobacter species), all with the ESBL phenotype 
and one Enterobacter species with the blaAmpC phenotype. 
The plates specificity was determined after monitoring the 
growth of the ESBL and blaAmpC positive bacteria on freshly 
prepared plates; while the plates shelf-life was determined 
by monitoring bacterial growth on the different plates after 
7, 14, 21 and 30 days of plates storage at 4-8oC. The plates 
were inoculated and incubated in ambient air at 35oC for 
18-24 hours. Following incubation, the plates were evaluated 
for the growth of any bacterial colonies. 
 Detection of low level carbapenemase producing 
blaOXA-48 Enterobacteriaceae on 0.5µg/ml Mac-Mem
 
 0.5µg/ml Mac-Mem agar plates were inoculated with colo-
nies from 16 blaOXA-48 producing members from the En-
terobacteriaceae family (14 Klebsiella pneumoniae and 2 E. 
coli). The MIC’s of the isolates tested to the 3 carbapenems 
were determined by the E-test®. All inoculated plates were 
incubated in ambient air at 35oC for 18-24 hours. Following 
incubation, bacterial colonies were counted and the LOD of 
each plate was determined in order to evaluate the analytical 
sensitivity of the 0.5µg/ml Mac-Mem for detecting blaOXA-48 
producing CRE’s. 
Detection of CRE’s on 0.5 µg/ml Mac-Mem agar 
from clinical patient samples
0.5µg/ml Mac-Mem agar plates were incorporated from Jan-
uary 2012 till April 2013 into CBH active surveillance system 
for the detection of drug resistant bacteria (19). During the 
study period, 2,784 swabs were collected from three body 
sites (nose/throat, umbilical/axillary, and rectal) of patients 
referred to CBH for admission from other medical institutions. 
All three swabs were inoculated on MacConkey agar with 
10µg/ml Cefotaxime (Mac-CTX), 5% Sheep Blood Agar with 
6µg/ml vancomycin, 5% Sheep Blood Agar (Hy-Lab Rehovot) 
and 0.5µg/ml Mac-Mem. Inoculated plates were incubated in 
ambient air at 35oC for 18-24 hours. Any bacterial growth 
on any of the selective media was worked up according to 
the Clinical Microbiology Procedures Handbook and their 
antimicrobial susceptibility testing was performed according 
to the Clinical and Laboratory Standard Institute guidelines 
(CLSI) (16, 17). 
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Results
Analytical sensitivity of the 0.5 µg/ml and 1.0 µg/
ml Mac-Mem, Mac-Imp and Mac-Ert Agar plates
The lowest number of bacterial colony forming units (LOD) 
for each of the three plates Mac-Mem, Mac-Imp and Mac-
Ert was determined for the two antibiotic concentrations in 
duplicate and the LOD testing was repeated three times with 
similar results. Moreover, the MIC’s of carbapenem resistant 
bacteria to the three carbapenems, were also determined 
(Table 1). Of the three carbapenems evaluated, Mac-Ert 
plates gave the lowest number of CFU’s detected regard-
less of the concentration of the antibiotic used (0.5 µg/ml or 
1.0µg/ml). With the exception to the K. pneumoniae with the 
blaOXA-48 carbapenem resistance mechanism which failed to 
grow on both Mac-Ert concentrations. The Mac-Ert plate low-
est LOD for all of the carbapenem resistant bacterial strains 
tested was <15 CFU’s, regardless of their carbapenem MIC’s 
(Table 1). There was a statistical significance (p-value <0.05) 
between the LOD of the Mac-Ert, for the majority of the 
organisms tested, when compared to the Mac-Mem and the 
Mac-Imp (Table 1). 
On the other hand, the 0.5µg/ml Mac-Mem plates detected 
all 10 strains of carbapenem resistant bacteria, however at a 
Table 1. Limit of Detection of the three carbapenem impregnated MacConkey Agar plates.
Bacterial Strain
Bacterial Isolates MIC’s 
(E-Test) mg/L*
Limit of Detection (CFU) of
 0.5 µg/ml Plates**















































Klesiella pneumoniae ( blaKPC ) 57449 ≥32 ≥32 ≥32 1 1 9 1 1 13
E. coli ( blaKPC) 41807 8 32 4 1.6 x 10
3 ~ NG 1 # 9.1 x 105 NG 1
Citrobacter species ( blaKPC ) 46685 32 24 24 2.5 x 10
5 ~ NG 1 # 2.2 x 108 NG 1
Enterobacter species( blaKPC ) 40426 ≥32 ≥32 ≥32 4 
~ 1,204 1 # 523 NG 1
Klebsiella pneumoniae ( blaKPC) 40926 ≥32 ≥32 ≥32 17 
~ 108 1 # 5.5 x 103 1.9 x 104 1
Klebsiella pneumoniae ( blaKPC ) 59313 ≥32 ≥32 ≥32 43 
~ 2.3 x 103 1 # 3.9 x 103 NG 1
Enterobacter species( blaKPC) 42783 ≥32 ≥32 ≥32 1 
~ 310 1 5 NG 1
E. coli ( blaKPC) 47961 ≥32 16 12 290 
~ NG 2 # 1.4 x 105 NG 2
Klebsiella pneumoniae ( blaOXA-48 ) 0.75 2 ≥32 1.1 x 10
6 ~ NG NG NG NG NG
Acinetobacter baumannii MDR ≥32 ≥32 ≥32 1 1 1 1 1 1
NG = No Growth; *MIC = Minimal Inhibitory Concentration; ** Limit of Detection is the lowest number of colony forming units that 
was detected on the different plates. 
#Statistically significant difference, p Value (<0.05), between LOD of Mac-Ert and both the Mac-Mem and Mac-Imp. 
~Statistically significant difference, p Value (<0.05), between LOD of Mac-Mem and Mac-Imp.
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higher LOD. The 0.5µg/ml Mac-Mem plates detected 8 out 
of the 10 strains at a limit of detection of ≤ 1.6 x 103 CFU’s, 
while the lowest LOD for the Citrobacter species blaKPC and 
the K. pneumoniae blaOXA-48 were 2.5 x 10
5 and 1.1 x 106 
CFU’s, respectively. Higher LOD was noted for the 1.0µg/
ml Mac-Mem agar in addition to its failure to detect the 
K. pneumoniae blaOXA-48 (Table 1). The worst performance 
was noted for the imipenem plate regardless of the antibiotic 
concentration used as a number of blaKPC producing bacterial 
strains in addition to the Klebsiella pneumoniae blaOXA-48 
positive strain failed to grow on the 0.5µg/ml and the 1.0µg/
ml plates (Table 1). There was a statistical significance (p-
value <0.05) between the LOD of the Mac-Mem, for the 
majority of the organisms tested, when compared to the 
Mac-Imp (Table 1). All three plates tested at both antibiotic 
concentrations had low limit of detection (1 CFU) for the 
multi-drug resistant Acinetobacter baumannii.
Specificity of the Mac-Mem, Mac-Imp and the 
Mac-Ert Agar plates. 
 Six members of the Enterobacteriaceae family (K. pneumoni-
ae, Salmonella species, Shigella species, E. coli, Proteus spe-
cies, and Citrobacter species), all with the ESBL phenotype, 
in addition to one Enterobacter species with the blaAmpC 
phenotype were used to evaluate the specificity of the plates 
for detecting carbapenem resistant bacterial strains in tripli-
cate. Mac-Mem plates showed the best specificity among the 
carbapenem plates tested, as none of the strains grew on 
either the 0.5µg/ml or the 1.0µg/ml Mac-Mem plates (Table 
2). On the other hand, the Mac-Ert plates consistently failed 
to inhibit the growth of the Citrobacter and the Enterobacter 
species tested at both antibiotic concentrations and the Pro-
teus species tested at the 0.5µg/ml antibiotic concentration. 
As for Mac-Imp plate, it showed poor specificity as both an-
tibiotic concentrations consistently failed to inhibit the growth 
of the Proteus, Enterobacter and Citrobacter species evalu-
ated (Table 2).
Shelf-life of the 0.5µg/ml and 1.0µg/ml Mac-Mem, 
Mac-Imp and Mac-Ert Agar plates 
Six members of the Enterobacteriaceae family (K. pneumoni-
ae, Salmonella species, Shigella species, E. coli, Proteus spe-
cies and Citrobacter species) all with the ESBL phenotype, 
in addition to one Enterobacter species with the blaAmpC 
phenotype were utilized to evaluate the shelf-life of the dif-
ferent plates in triplicate after 7, 14, 21 and 30 days. None of 
the bacterial isolates grew on the 0.5µg/ml or the 1.0µg/ml 
Mac-Mem plates after plates storage for 30 days at 4-8oC. 
On the other hand, bacterial growth was noted on the stored 
Mac-Imp and Mac-Ert plates after one day of the plates prep-
aration, and after 7, 14, 21 and 31days of plates storage for 
some of the isolates. 
Evaluation of the 0.5µg/ml Mac-Mem agar plates 
for the detection of low level carbapenemase 
producing blaOXA-48 Enterobacteriaceae 
The analytical sensitivity of the 0.5µg/ml Mac-Mem agar plates 
was determined on 16 blaOXA-48 positive Enterobacteriaceae 
(14 K. pneumoniae and 2 E. coli) in duplicate (Table 3). The 
16 blaOXA-48 positive Enterobacteriaceae MIC’s (mg/L) of the 
three carbapenems widely varied (Table 3). For meropenem, 
the MIC’s were between 0.25 and 16, for imipenem between 
0.5 and 8, while for ertapenem between 0.75 and >32. Con-
sistent with the low meropenem MIC’s, the limit of detec-
tion of the 0.5µg/ml Mac-Mem agar varied between 3.0E+05 
(CFU/ml) and ≤ 6.60E+06. One of the isolates growth was 
completely inhibited (Table 3). 
Table 2.  Growth of bacterial strains with the ESBL phenotype and Enterobacter species with blaAmpC phenotype on the 











K. pneumoniae NG / NG NG / NG NG / NG
Salmonella species NG / NG NG / NG NG / NG
Shigella species NG / NG NG / NG NG / NG
E. coli NG / NG NG / NG NG / NG
Proteus species NG / NG G / G G / NG
Citrobacter species NG / NG G / G G / G
Enterobacter species NG / NG G / G G / G
NG = No growth ; G = Growth
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Table 3.  Limit of detection of blaOXA-48 producing Enterobacteriaceae on the 0.5 µg/ml meropenem plates and the MIC’s 
to the 3 carbapenems
blaOXA-48 Positive 
Bacteria
Carbapenem MIC mg/L determined by E-Test Limit of 
Detection(CFU) of 
0.5mg/mL Mac-MemMeropenem Imipenem Ertapenem
K. pneumoniae 1560 0.5 1.5 1.5 6.60E+05
K. pneumoniae 1937 0.5 1 1 3.00E+05
K. pneumoniae 2301 0.5 0.75 >32 1.68E+06
K. pneumoniae 2307 0.5 1 2 2.04E+06
K. pneumoniae 2663 0.5 1 3 ND
K. pneumoniae 2806 4 1 >32 7.8E+05
K. pneumoniae 2213 16 8 >32 3.0E+05
K. pneumoniae 2214 0.38 2 4 1.14E+06
K. pneumoniae 2215 0.75 0.75 2 1.44E+06
K. pneumoniae 2216 0.38 0.75 12 4.68E+05
K. pneumoniae 2217 0.75 2 >32 3.00E+05
K. pneumoniae 3856 0.38 0.75 1 3.00E+05
K. pneumoniae 4451 0.25 0.5 8 6.60E+06
K. pneumoniae 4529 0.38 4 2 3.12E+06
E. coli 3856F 0.38 0.75 2 1.38E+06
E. coli 3856NF 0.5 0.75 0.75 6.60E+05
ND = Not Detected
Detection of CRE in clinical patient samples 
inoculated on 0.5µg/ml Mac-Mem agar plates 
The 0.5µg/ml Mac-Mem Agar plate was included in panel 
of plates used in the active bacterial drug resistance surveil-
lance program at CBH (19). From the 2,784 inoculated swabs, 
59 carbapenem resistant strains of bacteria were isolated on 
the 0.5µg/ml Mac-Mem plates and on the Mac-CTX. These 
include K. pneumoniae blaKPC (N=12), Enterobacter cloacae 
blaKPC (N = 2), Enterobacter cloacae blaVIM (N=1), Klebsiella 
pneumoniae blaOXA-48 (N=16), E. coli blaOXA-48 (N=3), multi-
drug resistant Acinetobacter baumannii (N=10), multi-drug 
resistant Pseudomonas aeruginosa (N = 10), and Stenotro-
phomonas maltophilia (N=5). Thus, the clinical sensitivity, 
specificity, positive predictive values and negative predictive 
values for the Mac-Mem when compared to the Mac-CTX 
were 100%. 
It was of importance to note that other types of Gram-neg-
ative bacteria grew on the 0.5µg/ml Mac-Mem plate. These 
include Pseudomonas aeruginosa strains that were not re-
sistant to meropenem but had a meropenem MIC greater 
than 0.5µg/ml. In addition, bacterial strains (N=20) from the 
Enterobacteriaceae family carrying the blaAmpC β-lactamase 
grew on the primary streak zone of the 0.5µg/ml merope-
nem. These isolates that hyper produce blaAmpC β-lactamase 
were not included in the study but their isolation was of 
importance from an infection control point of view.
Discussion
Rapid, sensitive and cost effective ways are of utmost impor-
tance for the early detection of CRE’s in patient samples. In 
this study we evaluated the performance of MacConkey agar 
plates impregnated with different concentrations (0.5µg/ml 
or 1.0µg/ml) of one of the three commonly used carbap-
enems; meropenem, imipenem and ertapenem. In addition, 
the plates’ specificity to detect carbapenem resistant bacte-
ria, their shelf-life at 4-8oC and their cost effectiveness were 
determined. 
The Mac-Ert with either of the two antibiotics concentrations 
showed the best LOD of the blaKPC positive Enterobacte-
riaceae. On both plate concentrations the lowest LOD was 
between 1 and 13 CFU’s (Table 1). Surprisingly, both Mac-Ert 
plates did not support the growth of the blaOXA-48 produc-
ing K. pneumoniae strain used in the evaluation (Table 1). 
The overall performance of the Mac-Ert plates was similar 
to that reported by Nordman et al., who reported an LOD 
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of <500 CFU/mL for some of the Enterobacteriaceae mem-
bers that were cultured on the Supercarba medium (Drigalski 
agar-base culture medium containing 0.25µg/ml ertapenem, 
250µg/ml cloxacillin and 70µg/ml ZnSO4) (14). However, the 
Supercarba medium supported the growth of the blaOXA-48 
positive strains (14). Unlike its excellent LOD, the specificity 
and the shelf-life of the Mac-Ert plates were poor as Citrobac-
ter species with the ESBL phenotype and Enterobacter species 
with the blaAmpC phenotype grew on the plates (Table 2). 
Consistent with what was noted on the Mac-Ert plates, some 
bacterial strains carrying the blaAmpC phenotype grew on the 
Supercarba medium (14). Similar to the low LOD of Mac-Ert 
to the blaKPC positive Enterobacteriaceae, it was also shown 
by Lolans et al., that the utilization of two 10µg/ml ertap-
enem disks on MacConkey agar can facilitate the detection 
of blaKPC positive bacteria (20). Interestingly, in that study the 
authors did not evaluate the growth of different ESBL and 
blaAmpC positive Enterobacteriaceae around the ertapenem 
disks. 
Unlike the Mac-Ert plates, both concentrations of the Mac-Imp 
plates (0.5µg/ml or 1.0µg/ml) gave poor sensitivity, specific-
ity and shelf-life. Both concentrations of the Mac-Imp plates 
failed to inhibit the growth of Proteus species and Citrobacter 
species with the ESBL phenotype, and Enterobacter species 
with the blaAmpC phenotype (Table 2). In addition to the 
poor specificity, the plates’ shelf-life was extremely short as 
the Mac-Imp plates failed to inhibit the growth of two of the 
ESBL positive isolates and the blaAmpC positive isolate tested. 
The LOD of the Mac-Imp plates evaluated in this study was 
similar to that reported by Adler et al. who showed that the 
MacConkey agar impregnated with 2µg/ml imipenem had a 
limit of detection between 1.1E+02 and 8.3E+06 (15); how-
ever, the authors did not evaluate the shelf-life of the plate. 
The 0.5µg/ml Mac-Mem plates gave suitable LOD for the 
blaKPC positive Enterobacteriaceae when compared to the 
1.0µg/ml Mac-Mem agar plates as the lowest LOD was less 
than 2.0E +03 for the majority of the blaKPC positive bacteria 
(Table 1). One Citrobacter species gave an LOD of 2.5E+05 
CFU/ml in the 0.5µg/ml Mac-Mem plate. The LOD of the 
0.5µg/ml Mac-Mem plates for the detection of blaKPC posi-
tive Enterobacteriaceae was similar to that reported by Nord-
man et al. who reported an LOD of <500 CFU/ml for some of 
the Enterobacteriaceae members (14). However, in the study 
conducted by Nordman et al. the authors did not evaluate 
blaKPC positive Citrobacter species (14). Consistent with the 
excellent sensitivity, the specificity of the 0.5µg/ml Mac-Mem 
plates was excellent as the plates prevented the growth of 
both ESBL and blaAmpC positive tested members of the En-
terobacteriaceae family (Table 2). The specificity of the 0.5 
and 1.0µg/ml Mac-Mem plates was the best when compared 
to the Mac-Ert and the Mac-Imp plates. 
The 0.5 µg/ml Mac-Mem agar long shelf-life (30 days) was 
of considerable importance since the laboratory technologist 
can prepare the medium and stores it at 4-8oC for up to 
four weeks. With the current work load and the number of 
employees available in the clinical microbiology laboratory, 
such long shelf-life is of importance. The four week shelf-life 
is much longer than the one week shelf-life of the Supercarba 
medium (14). 
The preparation of the 0.5µg/ml Mac-Mem plates in the clini-
cal laboratory was cost effective. In Palestine, the direct cost 
of preparing the plate was 0.33 USD. The cost is cheaper 
than the CHROMagarTM KPC and the 1.0µg/ml imipenem 
MacConkey Agar which cost $2.1 and $0.7, respectively (15). 
Estimated cost analysis of the Supercarba medium is above 
the cost of the 0.5µg/ml Mac-Mem agar plates.
 
The 0.5µg/ml Mac-Mem agar plate excellent analytical sen-
sitivity, specificity, low cost and long shelf-life prompted the 
utilization of this screening plate on 2,748 patient swab sam-
ples for the presence of carbapenem resistant Gram-negative 
bacteria. The 0.5µg/ml Mac-Mem agar plate inhibited the 
growth of non-carbapenem resistant bacteria and allowed 
for the isolation of 59 different bacterial strains with differ-
ent carbapenem resistant mechanisms. The isolation of these 
pathogens was at least 24-48 hours faster than isolating them 
on MacConkey agar impregnated with the third generation 
cephalosporin Cefotaxime (Mac-CTX). This was of utmost im-
portance since it allowed the microbiology laboratory person-
nel to report the isolation of these pathogens to the infection 
control team who took the necessary precautions to prevent 
the spread of these pathogens in the hospital setting. How-
ever, one of the drawbacks that were noted after utilizing the 
0.5 µg/ml Mac-Mem was the growth of bacterial strains with 
the blaAmpC phenotype on the primary streak zone of the 
plate. The growth of bacterial strains carrying the blaAmpC 
phenotype was also reported on the Supercarba medium but 
to a much lower extent. However, the authors added 250µg/
ml cloxacillin to reduce the chance that these bacterial strains 
that hyper produce the blaAmpC will grow (14). In our study 
we opted not to add the cloxacillin since the detection of 
bacterial isolates with the blaAmpC phenotype did not occur 
frequently. The other drawback of utilizing the meropenem 
instead of ertapenem was the high LOD of the blaOXA-48 
positive bacteria. Overall, the LOD of the blaOXA-48 positive 
bacteria was around 1.4E+06. This was higher than the LOD 
reported by Nordmann et al. who showed that depending 
on the blaOXA-48 positive bacteria, the LOD can be as low 
as 1 CFU/mL to 5.0E+02 CFU/mL (14). The higher LOD of 
blaOXA-48 positive bacteria on the 0.5µg/ml Mac-Mem plate 
did not compromise the bacterial detection as 16 isolates 
were detected on both the 0.5µg/ml Mac-Mem and the 10 
µg/mL Mac-CTX plates. 
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Overall, the 0.5µg/ml Mac-Mem agar plate can be used as 
a cost effective selective medium for the isolation of car-
bapenem resistant Gram-negative bacteria in particular the 
ones induced by the blaKPC carbapenem resistance mecha-
nism. Not only that, but the 0.5µg/ml Mac-Mem agar allows 
for the detection of other carbapenem resistant mechanisms 
such as blaVIM and blaOXA-48. In areas where carbapenem 
resistance mechanism is endemic this plate can be used to 
rapidly assist the infection control practitioners in controlling 
the spread of these pathogens.
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